Clinical Trial Update: Dose Painting of Head and Neck Cancer [NA]

View source ↗

Summary

Clinical trial NCT03847480 at Oslo University Hospital has an update on dose painting for head and neck cancer with the study status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Oslo University Hospital | Conditions: Head and Neck Cancer | NA | Status: COMPLETED